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Abstract D-2-Hydroxyglutaric aciduria is an inborn error of
metabolism ¢rst described in 1980. To date, more than 40 pa-
tients have been diagnosed with this disease. To identify the
metabolic precursor of D-2-hydroxyglutarate (D-2-HG), cultured
human lymphoblasts from two patients with D-2-HG aciduria
were grown in culture medium supplemented with [U-13C6]-
glucose or [2H5]glutamate. Mass isotopomer distribution mea-
surements of D-2-HG, 2-ketoglutarate (2-KG) and citrate were
performed by gas chromatography-mass spectrometry. The
mass isotopomer distributions in D-2-HG, 2-KG and citrate,
following [U-13C6]glucose and [2H5]glutamate incubations, re-
vealed that 2-KG interconverts rapidly to D-2-HG and that
D-2-HG is formed within the mitochondria.
2 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
2-Hydroxyglutarate (2-hydroxypentanedioic acid, 2-HG) is
a ¢ve carbon dicarboxylic acid in which the K carbon carries a
hydroxy group. Therefore 2-HG occurs in two enantiomeric
con¢gurations: D (R), and L (S). In the 1970s, it was recog-
nized that 2-HG is a normal constituent of human urine [1,2].
Since 1980, the interest in 2-HG has increased markedly as
patients were described who excreted large amounts of 2-HG
[3,4]. By using chiral derivatization followed by gas chromato-
graphic analyses, the two enantiomeric forms of 2-HG could
be individually detected, resulting in the ¢nding of two new
organic acidurias: D-2-HG aciduria (D-2-HGA) [3] and L-2-
HG aciduria (L-2-HGA) [4]. The present report focuses on
D-2-HGA.
At this moment more than 40 patients have been diagnosed
with D-2-HGA. Clinical symptoms of these patients are: de-
velopmental delay, epilepsy and hypotonia and, less fre-
quently, movement disorders and cardiomyopathy. Some pa-
tients show dysmorphic features. Magnetic resonance imaging
(MRI) of the brain reveals disease-speci¢c alterations in all
patients. The clinical and biochemical features of 25 D-2-HGA
cases were reviewed by Van der Knaap et al. [5,6].
Urinary 2-HG is elevated not only in D-2-HGA or L-2-
HGA but also in combined D- and L-2-HG aciduria [7], glu-
taric aciduria type II (D-2-HG) [8], deafness-onychodystrophy-
osteodystrophy-retardation syndrome [9], pyruvate decarbox-
ylase de¢ciency [10], dihydrolipoyl dehydrogenase de¢ciency
[11], malonic aciduria [12], and K-amino/K-ketoadipic aciduria
[13]. With the exception of glutaric aciduria type II, enantio-
meric di¡erentiation of the elevated 2-HG has not been re-
ported.
The origin of D-2-HG in D-2-HGA is still not clear, in spite
of the fact that 2-HG is known to be involved in di¡erent
metabolic pathways. Three mammalian pathways involving
2-HG are known. First, a mitochondrial enzyme that dehy-
drogenates D-2-hydroxyacids to their 2-keto-analogs was iden-
ti¢ed in rabbit kidney by Tubbs et al. [14]. Second, a hydroxy-
acid^oxoacid transhydrogenase, present in rat kidney, liver,
and brain converts 2-ketoglutarate (2-KG) to D-2-HG in a
reaction in which Q-hydroxybutyrate is converted to succinic
semialdehyde [15]. Third, D-2-HG is an intermediate in the
metabolism of 5-hydroxy-L-lysine and 2-keto-5-hydroxyadi-
pate is its direct precursor [16]. In addition to these three
mammalian pathways, D-2-HG-involving pathways have
been described in bacteria. First, a 3-phosphoglycerate dehy-
drogenase in Escherichia coli also has a 2-KG reductase ac-
tivity yielding 2-HG [17]. Second, the condensation of glyoxy-
late and propionyl-CoA by E. coli produces D-2-HG [18].
Third, 2-aminoadipate is converted to D-2-HG by Pseudomo-
nas putida [19].
Analysis of urinary organic acids from D-2-HGA patients
shows that in addition to the massive excretion of D-2-HG,
the concentrations of citric acid cycle (CAC) intermediates are
frequently elevated, implying a link between D-2-HG and the
CAC [5,6].
Here, we present a study in which lymphoblasts of a control
and two D-2-HGA patients were grown on media supple-
mented with either [U-13C6]glucose or [2H5]glutamate. The
13C and 2H mass isotopomer distributions [20] of citrate,
2-KG and 2-HG were used to identify the precursor of D-2-
HG, and the subcellular location of its formation.
2. Materials and methods
2.1. Chemicals
[U-13C6]glucose (s 97% isotopic purity), D-2-HG, L-2-HG, 2-KG,
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and ethoxylamine HCl were purchased from Sigma (St. Louis, MO,
USA). [2,3,3,4,4-2H5]Glutamate (98% isotopic purity) was from CDN
Isotopes (Quebec, QC, Canada). R-(3)-2-Butanol was purchased
from Aldrich (St. Louis, MO, USA). Solid-phase extraction cartridges
containing 60 mg OASIS HLB were from Waters (Milford, MA,
USA). Lymphoblast culture medium RPMI 1640 was purchased
from Gibco (Grand Island, NY, USA). Diazomethane was prepared
according to the procedure of De Boer [21]. All other chemicals and
solvents used were of analytical grade.
2.2. Cell lines
Human lymphoblast cell lines were established by Epstein^Barr
virus transformation of leukocytes derived from whole blood. The
lymphoblast cell lines were grown in RPMI 1640 supplemented with
10% fetal bovine serum and 1% penicillin/streptomycin. [U-
13C6]Glucose incubations were performed by the addition of the steri-
lized labelled substrate to the complete medium in a 1:1 ratio towards
the native unlabelled D-glucose content: 11 mM. [2H5]Glutamate in-
cubations were performed by the addition of the sterilized labelled
substrate (adjusted to pH 7.4) to the complete medium in a 10:1 ratio
towards the native unlabelled glutamate content: concentration
[2H5]glutamate 1.4 mM. The amounts of labelled substrates added
to the culture medium were chosen after pilot experiments identi¢ed
the minimal substrate enrichments needed to allow accurate measure-
ments of (small) enrichments in the products.
One D-2-HGA lymphoblast cell line was from a male patient with
neonatal onset of the disease and a¡ected with the severe phenotype
(patient 3 in Van der Knaap et al.’s review [5]). Clinically, the boy
su¡ered from hypotonia, seizures, epilepsy and developmental delay.
MRI revealed major alterations including enlarged lateral ventricles
and delayed myelination. Laboratory analysis of urine, plasma and
cerebrospinal £uid showed strongly elevated levels of D-2-HG (s 200
times normal) and normal levels of L-2-HG.
The second D-2-HGA lymphoblast cell line was from a female pa-
tient with onset of the disease at 11 months and a¡ected with the mild
phenotype (patient 6 in Van der Knaap et al.’s review [6]). The girl
su¡ered from psychomotor and mental retardation and cardiomyo-
pathy. MRI, obtained at the age of 9 years, revealed multifocal small
white matter lesions, spread over the cerebral white matter in both
periventricular and subcortical areas. Laboratory analysis of urine
and plasma showed elevated levels of D-2-HG (s 40 times normal)
and normal levels of L-2-HG.
The control lymphoblast cell line was originally obtained for carrier
screening for an autosomal recessive disorder not related to D-2-HGA,
and found to be normal.
Each cell line was cultured in (1) regular RPMI 1640 medium, (2)
[U-13C6]glucose-supplemented medium and (3) [2H5]glutamate-supple-
mented medium. All incubations were performed in triplicate. At the
start of the incubation, each 25-cm2 £ask contained approximately
100 000 cells/5 ml of the appropriate medium. After 96 h of incubation
in a 5% CO2^95% air incubator at 37‡C, the medium was collected by
centrifugation for 5 min at 1500Ug. The cell-free medium was stored
at 320‡C until further analysis. The cell pellet was washed three times
with Hanks’ balanced salt solution, and the dry cell pellet was stored
at 20‡C until protein determination [22].
2.3. Determination of the mass isotopomer distributions of D- and
L-2-HG
The analytical procedure for the determination of D- and L-2-HG
was according to Gibson et al. [23] with some modi¢cations. After the
addition of 50 Wl 6 M HCl to 1 ml cell medium (pH6 1), D- and L-2-
HG were extracted using OASIS HLB solid-phase extraction car-
tridges. Brie£y, the cartridge was pre-conditioned with 750 Wl of meth-
anol followed by 750 Wl of 0.1 M HCl. After loading the sample by
gravity, the cartridge was washed with 750 Wl of 0.1 M HCl. The
analytes were eluted from the cartridge with 800 Wl of methanol. After
drying the methanolic eluate under nitrogen at 50‡C, a two-step deri-
vatization procedure yielded the di-R-(3)-butyl-O-acetyl derivatives of
D- and L-2-HG. Gas chromatography-mass spectrometry (GC-MS)
analyses were performed on a Hewlett Packard 5890 series II gas
chromatograph, equipped with a CP-Sil 88 CB (Chrompack, The
Netherlands) capillary column, and linked to a Hewlett Packard En-
gine 5989B mass spectrometer. The mass spectrometer was used in the
positive chemical ionization mode using 5% NH3 in methane as re-
agent gas. The distribution of the M to M5 mass isotopomers was
monitored at m/z 303^308.
2.4. Determination of the mass isotopomer distributions of 2-KG
To 500 Wl of cell medium 200 Wl (100 g/l) ethoxylamine in H2O was
added after which the mixture was heated at 60‡C for 30 min at
pH6 1, to obtain the stable ethoxime derivative of the unstable
K-keto group. The derivative was extracted using the same solid-phase
extraction procedure as described for 2-HG. The methanolic eluate
was blown to dryness under nitrogen at 50‡C. Dimethyl derivatives
were prepared by treatment of the residue with 20 Wl of methanol
and 180 Wl diazomethane in ether. After a period of 5 min at room
temperature, the solution was blown to dryness and the residue dis-
solved in 50 Wl of ethyl acetate. GC-MS analysis was performed using
the same set-up as described for the measurement of 2-HG. The
distribution of the M to M5 mass isotopomers was monitored at
m/z 218^223.
2.5. Determination of the mass isotopomer distributions of citrate
Citrate was extracted by the above-mentioned solid-phase extrac-
tion procedure, from 500 Wl of culture medium, which was acidi¢ed by
the addition of 25 Wl of 6 M HCl. After the methanolic eluate was
blown to dryness under nitrogen at 50‡C, treating the dry residue with
20 Wl of methanol and 180 Wl diazomethane in ether formed the
trimethyl derivative of citrate. After 5 min at room temperature, the
solution was blown to dryness and the residue dissolved in 50 Wl of
ethyl acetate. GC-MS analysis was performed using the same set-up
as described for the measurement of 2-HG. The [M+NH4]þ ion was
found to be the most abundant ion for the GC-MS measurement of
trimethylated citrate. The distribution of the M to M6 mass isotopom-
ers was monitored at m/z 252^258. Unlabelled standards of D- and
L-2-HG, 2-KG, and citrate were included in each sample set to verify
the GC-MS mass calibration, and to assess the absence of contami-
nants at all m/z monitored.
2.6. Quantitative measurement of unlabelled 2-HG, 2-KG, and citrate in
regular medium
The analytical work-up for 2-HG, 2-KG, and citrate in regular
medium without the addition of labelled substrates, was performed
as described in Sections 2.3, 2.4, and 2.5. Prior to the analysis, the
following stable isotope-labelled internal standards were added to
the corresponding samples: K-keto[3,3,4,4-2H4]glutarate and [2,2,4,4-
2H4]citrate (Euriso-Top, Gif-sur-Yvette, France) and D/L-2-hydroxy-
[3,3,4,4-2H4]glutarate, prepared by chemical reduction of K-keto-
[3,3,4,4-2H4]glutarate as described previously [21]. Calibration curves
were prepared with increasing amounts of analyte and a constant
amount of the stable isotope-labelled internal standard. In the GC-
MS analysis, the following single-ion monitoring settings were per-
formed (m/z analyte; m/z internal standard): 2-HG (m/z 303; m/z
307), 2-KG (m/z 218; m/z 222), and citrate (m/z 252; m/z 256).
2.7. Calculations of enrichments in 2-HG, 2-KG, and citrate
The enrichments were calculated based on the results of the GC-MS
measurements of the analytes of interest. Enrichments are expressed
as molar percentage excess (MPE) and for the incubations performed




peak area of isotopomer corrected for natural enrichment
P ðall corrected peak areas of the analyteÞ U100
TE ¼
P ð1 to iÞ of ðMPEiUiÞ
number of C atoms in the underivatized molecule
where i represents the number of carbon atoms which can be labelled
in the underivatized molecule and MPEi represents the MPE of the
speci¢c isotopomer. Note that TE represents the average fraction of
carbon atoms that are labelled in the underivatized analyte. For an
extensive discussion of these calculations, see [20].
In the nomenclature of mass isotopomers, the unlabelled species is
designated M. Isotopomers containing 1 to n heavy atoms (13C or 2H)
are designated M1 to Mn.
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3. Results
3.1. Levels of 2-HG, 2-KG, and citrate in media of cells grown
on unsupplemented medium
The amounts of 2-HG, 2-KG, and citrate formed by the
cultured lymphoblasts grown in regular RPMI 1640 medium
are displayed in Table 1. The values were corrected for the
levels of 2-HG, 2-KG, and citrate present in blank unincu-
bated culture medium. The D-2-HGA cell lines accumulated
D-2-HG with an average amount of 52 nmol and 34 nmol per
mg protein after a 96-h incubation for the severe and mild cell
line respectively. No D-2-HG could be detected in the culture
medium of the control cell line. This shows that D-2-HGA
lymphoblasts are suitable for biochemical investigations re-
lated to D-2-HGA. The levels of citrate in the cell medium
were comparable for all cell lines, while the level of 2-KG in
the medium of the severe D-2-HGA cell line was more than six
times that in the media of the control cell line and the mild
D-2-HGA cell line.
3.2. 13C mass isotopomer distributions of metabolites labelled
from [U-13C6]glucose
The 13C mass isotopomer distributions of 2-HG, 2-KG, and
citrate labelled from [U-13C6]glucose in the control cell line
and the D-2-HGA cell lines are presented in Table 2. The mass
isotopomer distributions of 2-KG and citrate were identical in
the three cell lines. All possible mass isotopomers (M0 to M5
for 2-KG, and M0 to M6 for citrate) were detected. The most
abundant isotopomer of 2-KG and citrate was the doubly
labelled M2 mass isotopomer.
No D- or L-2-HG was detected in the control cell line, thus
the enrichments of these compounds could not be measured.
The mass isotopomer distribution of D-2-HG in the media of
the two D-2-HGA cell lines strongly resembles that of 2-KG
and citrate in which also the M2 isotopomer was the most
abundant. The other isotopomers of D-2-HG found were M1,
M3, M4 and M5. L-2-HG was not detectable.
3.3. 2H mass isotopomer distributions of metabolites labelled
from [2H5]glutamate
L-Glutamate is closely related to 2-KG via transamination
and via glutamate dehydrogenase. In the three cell lines, high
proportions of the M4 isotopomer of 2-KG were found (Ta-
ble 3). The proportions of the M3 isotopomer were also mea-
sured in all cell lines with MPEs of approximately 7%. No
other isotopomers of 2-KG were detected. The only detected
mass isotopomer of citrate was M1, with MPEs of 2.1%, 2.3%
and 0.9% for the control, severe and mild D-2-HGA cell line
respectively.
For D-2-HG formed by the D-2-HGA cell lines, the M4
isotopomer (MPEs 9.1% and 10.1% for the severe and mild
cell line respectively) was the most abundant. Next to M4, the
M3 isotopomer was also present.
4. Discussion
The ongoing research into the underlying defect in D-2-
HGA has not been very successful since the ¢rst description
of the disease in 1980. The lack of knowledge about the met-
abolic origin of D-2-HG hampers biochemical studies focussed
on the cause of its accumulation in a¡ected patients. Recently,
we reported that cultured human ¢broblasts from patients
with D-2-HGA released high amounts of D-2-HG in the cul-
ture medium [24]. Further experiments showed that this was
Table 1
Formation of 2-HG, 2-KG, and citrate measured in cell culture me-







L-2-HG nda nd nd
D-2-HG nd 52T 9 34T4
2-KG 11T1.5 69T 14 10T2
Citrate 108T 24 144T 29 81T10
All the results were from three incubations per cell line, with single
GC-MS measurement per £ask, and are expressed as meanTS.D.
and, not detectable.
Table 2
13C enrichments expressed as MPE and TE in D-2-HG, 2-KG, and citrate measured in media of a control and two D-2-HGA cell lines grown
on [U-13C6]glucose-supplemented medium
Isotopomer Control cell line (MPE, %) D-2-HGA cell line,
severe phenotype (MPE, %)
D-2-HGA cell line,
mild phenotype (MPE, %)
D-2-HG M1 nda 7.8T 0.6 8.9 T 0.4
M2 nd 20.2T 0.2 19.2T 0.8
M3 nd 7.2T 0.4 6.9 T 0.5
M4 nd 4.4T 0.6 3.6 T 0.4
M5 nd 1.0T 0.4 1.1 T 0.2
TE nd 0.18T 0.004 0.18T 0.01
2-KG M1 6.5T 0.5 7.2T 0.1 8.9 T 1.0
M2 17.1T 0.5 18.7T 0.1 16.0T 0.7
M3 5.5T 0.9 6.1T 0.2 6.0 T 0.7
M4 4.0T 0.2 3.9T 0.2 3.1 T 0.2
M5 0.7T 0.2 1.2T 0.1 0.8 T 0.1
TE 0.15T 0.007 0.17T 0.001 0.15T 0.005
Citrate M1 5.6T 0.1 6.0T 0.03 3.6 T 0.4
M2 16.7T 0.2 18.0T 0.1 13.6T 0.4
M3 6.3T 0.1 6.6T 0.03 5.2 T 0.3
M4 4.7T 0.1 5.2T 0.1 3.9 T 0.1
M5 2.1T 0.1 1.9T 0.1 1.7 T 0.1
M6 0.43T 0.05 0.35T 0.05 0.30T 0.02
TE 0.15T 0.001 0.16T 0.001 0.14T 0.002
All the results were from three incubations per cell line, with single GC-MS measurement per £ask, and are expressed as meanTS.D.
and, not detectable.
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also true for human lymphoblasts, with the di¡erence that
these cells accumulated even more D-2-HG.
We took advantage of the availability of these cell lines and
of recent developments in mass isotopomer analysis of meta-
bolic pathways [20] to conduct a study on the origin of D-2-
HG. The physiological metabolite with a structure closest to
that of D-2-HG is 2-KG. 2-KG can be formed in mitochon-
dria via the CAC, glutamate dehydrogenase, or transamina-
tion of glutamate. It can also be formed in the cytosol via
transamination of glutamate. We designed a two-pronged
study to label 2-KG either via the mitochondrial reactions
of the CAC (using [U-13C6]glucose), or via a combination of
mitochondrial and cytosolic reactions (using [2H5]glutamate).
The mass isotopomer distributions of D-2-HG, 2-KG and cit-
rate labelled from the two tracers reveals the mitochondrial
origin of D-2-HG.
4.1. Experiments with [U-13C6]glucose
The mass isotopomer distributions of D-2-HG, 2-KG and
citrate labelled from [U-13C6]glucose (Table 2) result from
multiple passages of labelled molecules through the CAC
(Fig. 1). Brie£y, [U-13C6]glucose is ¢rst metabolized by gly-
colysis to [13C3]pyruvate, which is converted to [13C2]acetyl-
CoA and [13C3]oxaloacetate by pyruvate dehydrogenase and
pyruvate carboxylase respectively. At the level of succinate,
the 13C carbons originating from [13C2]acetyl-CoA are located
either on carbon positions 1 and 2 or on positions 3 and 4 as a
result of the symmetry in succinate. In three subsequent bio-
Table 3
2H enrichments expressed as MPE in D-2-HG, 2-KG, and citrate measured in media of a control and two D-2-HGA cell lines grown on
[2H5]glutamate-supplemented medium
Isotopomer Control cell line
(MPE, %)
D-2-HGA cell line,
severe phenotype (MPE, %)
D-2-HGA cell line,
mild phenotype (MPE, %)
D-2-HG M3 nda 2.2 T 0.2 3.2T 0.3
M4 nd 9.1T 0.5 10.1T 0.1
2-KG M3 7.7T 0.1 6.7 T 0.03 6.2T 0.5
M4 43T 0.2 38T0.6 22T 1
Citrate M1 2.1T 0.1 2.3 T 0.3 0.9T 0.1
All the results were from three incubations per cell line, with single GC-MS measurement per £ask, and are expressed as meanTS.D.
and, not detectable.
Fig. 1. The metabolic fate of 13C deriving from [13C6]glucose is represented in this ¢gure in which only the carbon backbones of the intermedi-
ates are shown. 13C atoms that are incorporated in the CAC intermediates are displayed in bold. The dashed arrow indicates the conversion of
[13C3]pyruvate to [13C3]oxaloacetate. For reasons of simplicity, 13C incorporation in CAC intermediates originating from [13C3]oxaloacetate is
not shown. See Sections 3 and 4 for explanation.
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chemical reactions, doubly labelled oxaloacetate is obtained,
which can start its second cycle by condensation with the pool
of acetyl-CoA, consisting of both unlabelled and doubly la-
belled molecules. In parallel, [13C3]oxaloacetate, formed by
carboxylation of [13C3]pyruvate by pyruvate carboxylase, con-
denses with the pool of labelled+unlabelled acetyl-CoA result-
ing in the M3 and M5 isotopomers of citrate. Lastly, after
multiple turns of the cycle, all possible mass isotopomers of
citrate are formed, provided that the enrichment of the
[U-13C6]glucose precursor is su⁄ciently high (in our case, it
was 50%).
In both D-2-HGA cell lines cultured with [U-13C6]glucose,
we found a strong identity between the distributions of the
M1 to M5 isotopomers of D-2-HG and 2-KG (Table 2). This
suggests that one of the two metabolites is the precursor of
the other, or that the two compounds are interconverted.
Also, the distribution of the M1 to M5 isotopomers of citrate
and 2-KG is very similar. This results from the fact that, in
the conversion of citrate to 2-KG, very little label is lost from
carbon 6 of citrate. Because of the reversibility of the reac-
tions catalyzed by aconitase and isocitrate dehydrogenase [25],
much of the label on the C6 of citrate is lost by isotopic
exchange with unlabelled CO2. Therefore, the almost identical
distributions of M1 to M5 isotopomers of D-2-HG, 2-KG and
citrate show that the three compounds are part of a metabolic
sequence. This is con¢rmed by the almost identical total en-
richment fractions of D-2-HG, 2-KG and citrate. Since citrate
is formed only in the mitochondria, the identity of the distri-
butions of the M1 to M5 isotopomers of citrate and 2-KG
shows that the labelling of the latter is not diluted by unla-
belled carbon derived from glutamate in the culture medium
(at least under our conditions). Then, the identity of the dis-
tributions of the M1 to M5 isotopomers of 2-KG and D-2-HG
shows that D-2-HG is formed in mitochondria from 2-KG.
4.2. Experiments with [2H5]glutamate
In orientating experiments with physiological concentra-
tions of [2H5]glutamate, we could not detect the labelling in
citrate. This is why we conducted all subsequent experiments
with 90% enriched [2H5]glutamate at a 10 times physiological
concentration. The unphysiological concentration of [2H5]
glutamate did not a¡ect the conclusions of the study (see
below). The interpretation of the 2H mass isotopomer distri-
bution of citrate, 2-KG and D-2-HG labelled from
[2H5]glutamate (Table 3) is based on the sequence of reactions
represented in Fig. 2. First in the conversion of [2H5] gluta-
mate to 2-KG catalyzed by glutamate dehydrogenase and
transaminases, 2H on the C2 of glutamate is lost to water.
This is why M4 2-KG is the most abundant labelled iso-
topomer of 2-KG. At the time of harvesting the MPEs of
M4 and M5 glutamate, measured by GC-MS as their dimeth-
yl-N-methylcarbamate derivatives, were 35 and 11% respec-
tively for the control and severe D-2-HGA cell line and 25
and 1% for the mild D-2-HGA cell line, showing the intercon-
version between glutamate and 2-KG.
In addition to M4 2-KG, there was a substantial abundance
of M3 2-KG in the media of the control and the D-2-HGA
cells (Table 3). The abundance of the M3 2-KG, about one
¢fth that of M4 2-KG, cannot be explained by the presence of
substantial amounts of M4 glutamate in the tracer. Indeed,
the abundance ratio M5/M4 in the glutamate tracer, 13, was
greater than the corresponding ratio M4/M3 in 2-KG. The
production of M3 2-KG results most likely from the reaction
of keto-enol tautomerism between C2 and C3 of 2-KG, result-
ing in partial loss of 2H on C3 (Fig. 3).
In the D-2-HGA cell lines, the abundances of the M4 and
M3 isotopomers of D-2-HG were two to ¢ve times lower than
those of the M4 and M3 isotopomers of 2-KG (Table 3). In
addition, the abundance ratios M4/M3 for the severe and mild
D-2-HGA cell lines, i.e. 4.1 and 3.8, were not very di¡erent
from the M4/M3 abundance ratios in 2-KG, i.e. 5.6 and 3.5.
This supports the previous conclusion that M4 and M3 2-KG
are related to M4 and M3 D-2-HG. However, when 2-KG is
labelled from [2H5]glutamate, there is a dilution of unlabelled
carbon between 2-KG and D-2-HG. In cells incubated with a
high concentration of 90% labelled [2H5]glutamate, there must
be a high concentration of highly labelled cytosolic 2-KG
derived from transamination of [2H5]glutamate. As cytosolic
2-KG enters the mitochondria via reversible transamination,
it gets diluted by unlabelled 2-KG. The origin of this unla-
belled 2-KG is evident from the very low enrichment of cit-
rate. In the steps between 2-KG and oxaloacetate (the pre-
cursor of citrate), most of the label of 2-KG is lost at the
rapidly reversible reactions catalyzed by succinate dehydroge-
nase, fumarase and malate dehydrogenase. Since the labelling
of citrate is very low, it generates unlabelled 2-KG in the next
turn of the CAC, thus diluting the label of 2-KG derived from
[2H5]glutamate.
In conclusion, the mass isotopomer distribution of citrate,
2-KG and D-2-HG released by cell cultured with [U-13C6]-
glucose or [2H5]glutamate demonstrates that mitochondrial
2-KG interconverts with D-2-HG. In addition, the similarity
of the isotopomer patterns of citrate, 2-KG and D-2-HG la-
belled from [U-13C6]glucose demonstrates the close relation-
Fig. 2. The metabolic fate of 2H (represented as d) deriving from
[2H5]glutamate is represented in this ¢gure starting with the conver-
sion of [2H5]glutamate to [2H4]2-KG. Subsequent losses of 2H
atoms during the passage through the CAC lead to [2H]oxaloacetate
in which the remaining 2H atom is ¢xed on the third C atom of the
molecule.
Fig. 3. The keto-enol tautomerism of 2-KG, resulting in the loss of
one 2H atom, non-enzymatically generates [2H3]2-KG from [2H4]2-
KG.
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ship of the CAC reactions with the reaction(s) forming D-2-
HG. The knowledge obtained in this study provides a step
forwards in the elucidation of the basic defect causing D-2-
HGA.
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